Clinical Trial Update: Intravenous Iron Isomaltoside 1000 (Monofer®) Compared With Oral Iron in the Treatment of Postgastrectomy Anemia: An Open-label Randomized Controlled Trial [Phase 4]

View source ↗

Summary

An open-label Phase 4 randomized trial comparing intravenous iron isomaltoside 1000 (Monofer) with oral iron in treating postgastrectomy anemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postgastrectomy Anemia

Drugs mentioned

• Monofer (Ferric derisomaltose)
• Oral iron (ferrous sulfate)

Snippet

Sponsor: Yonsei University | Conditions: Post Gastrectomy Anemia | Phase 4 | Status: UNKNOWN